Scientist, Allogeneic CAR-T Process Development

Location
Thousand Oaks, CA
Posted
Mar 21, 2019
Ref
614
Required Education
Doctorate/PHD/MD
Position Type
Full time

Process Sciences  Thousand Oaks, California

We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.
 

Position Summary

This position will work with the Technical Operations teams to develop and characterize cell therapy manufacturing processes and products, focusing on allogeneic CAR-T cells.  The Scientist will be responsible for contributing to the process development of allogeneic CAR-T cells to enable clinical trials.  Under minimal supervision, you will be expected to design and perform experiments, organize and carefully document results, analyze and interoperate results, and communicate findings.

Reports to:  Principal Scientist, Allogeneic CAR-T Process Development

Location:  Thousand Oaks (northwest Los Angeles area), CA

Primary Responsibilities

  • Contribute substantially the development of manufacturing processes for allogeneic CAR-T cells 
  • Independently designs and executes studies to facilitate development of allogeneic CAR-T processes and enabling clinical trials.  
  • Executes process development studies to develop a thorough understanding of operating and performance parameters (Design space). 
  • Incorporate bioreactor platforms and other scaleable technologies 
  • Sets up, monitors, samples and analyzes cell culture processes. 
  • Performs multiplexed cell-based assays (killing assays, mixed lymphocyte reactions, proliferation assays, etc.) for process assessment and product characterization. 
  • Role model for Atara’s Values of patients first, innovation teamwork, community and mindset. 

Education and Experience:

  • Ph.D. in Immunology, Cancer biology, or engineering science with >2 years of related industry experience. 
  • Experience with the generation and evaluation of human CAR-T therapies; Industry experience in adoptive T cell, CAR-T, or TCR therapeutics preferred. 
  • Experience with process characterization, scale-up and/or technology transfer preferred 
  • Familiarity with development and /or commercialization of cell-based therapeutics 
  • Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing priorities

 

More About Atara Bio:
Now in our sixth year, we’re proud of our team of 300+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.

One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”

The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.

Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).

Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV).

Working at Atara Bio:
People at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.

Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.

We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States.